Is this your brand? Sign in to claim ownership.

KING SYSTEMS CORPORATION.

Last updated September 17, 2026

Information

Country: US
Address: 15011 HERRIMAN BLVD., Noblesville, IN, 46060
Website: —
LinkedIn: —
Facebook: —
Email: —
Phone: —
PRRC Contact: —
EUDAMED SRN: —
FDA FEI Number: 1824226
DUNS Number: —

Catalogue (1113)

Page 21 of 23

Device	Model / Reference	Registries	Class	Status
Virobac Ii®	342077	FDA UDI	Class II	Active
Universal Flex2®breathing Circuit	DF0110-6121	FDA UDI	Class I	Active
Adult Ultra Flex®anesthesia Breathing Circuit	8903F-448Z	FDA UDI	Class I	Unknown
Universal F2®anesthesia Breathing Circuit	D360-808Z	FDA UDI	Class I	Active
Jackson Rees	61750	FDA UDI	Class I	Active
Universal Flex2®breathing Circuit	DF470-60Z	FDA UDI	Class I	Unknown
Disposable Xenon Kitfor Nuclear Medicine	20005	FDA UDI	Class II	Active
Universal Flex2®	CF070-61	FDA UDI	Class I	Active
Pediatric Ultra Flex®anesthesia Breathing Circuit	2615R-61	FDA UDI	Class I	Unknown
Pediatric Anesthesiabreathing Circuit	2606Y-19021	FDA UDI	Class I	Active
Adult Ultra Flex®anesthesia Breathing Circuit	5613F-61Z	FDA UDI	Class I	Active
Disposable Xenon Circuitfor Nuclear Medicine	22116	FDA UDI	Class II	Unknown
Universal F® Flexbreathing Circuit	KNUF375-6121Z21	FDA UDI	Class I	Unknown
Adult Anesthesiabreathing Circuit	8403F-6127Z	FDA UDI	Class I	Active
Ulti-MistHME/F Child	MS-101	FDA UDI	Class II	Active
Universal F2®anesthesia Breathing Circuit	D445-80Z	FDA UDI	Class I	Active
12" Nafion Line	7041	FDA UDI	Class I	Active
Universal F2®anesthesia Breathing Circuit	LC395-6121Z	FDA UDI	Class I	Active
Universal F2®anesthesia Breathing Circuit	D396R-61Z	FDA UDI	Class I	Active
Jackson Rees	4054-409Z	FDA UDI	Class I	Active
Universal F2®anesthesia Breathing Circuit	D466-8019ZP	FDA UDI	Class I	Unknown
Adult Ultra Flex®anesthesia Breathing Circuit	8612F-61Z	FDA UDI	Class I	Active
Universal Flex2®breathing Circuit	KNCF375-61Z	FDA UDI	Class I	Active
Disposable Xenon Circuitfor Nuclear Medicine	21105	FDA UDI	Class II	Unknown
Nitric Oxidedelivery Circuit	NO-101	FDA UDI	Class I	Active
Universal Flex2®breathing Circuit	DF475-6021Z	FDA UDI	Class I	Unknown
Universal F2®anesthesia Breathing Circuit	D345-61Z	FDA UDI	Class I	Unknown
Ped F2® Pediatricanesthesia Breathing Circuit	PDP260-6121	FDA UDI	Class I	Active
Universal F2®anesthesia Breathing Circuit	D440-176Z	FDA UDI	Class I	Unknown
Pediatric Ultra Flex®anesthesia Breathing Circuit	2704-61	FDA UDI	Class I	Active
Pediatric Ultra Flex®anesthesia Breathing Circuit	2706Y-80	FDA UDI	Class I	Active
Ventilator Circuit	40411-2	FDA UDI	Class I	Active
Jackson Rees	3731-366WSNZ	FDA UDI	Class I	Active
Universal F® Flex2®	NAF3116-6121Z	FDA UDI	Class I	Active
Ped F2® Pediatricanesthesia Circuit & Pack Kit	F90556	FDA UDI	Class I	Active
Universal F® Flex2®	AF476-6121Z	FDA UDI	Class I	Active
SAMPLING LINE, 10ft, .050, M/M	7066	FDA UDI	Class I	Active
Universal F2®anesthesia Breathing Circuit	NC395-6121Z	FDA UDI	Class I	Unknown
Universal Flex2®	CF370-6121Z	FDA UDI	Class I	Active
Pediatric Ultra Flex®anesthesia Breathing Circuit	2706P-4228	FDA UDI	Class I	Active
King LTS-D	KLTSD423	FDA UDI	Class I	Active
Custom Accessory	D054	FDA UDI	Class I	Active
Pediatric Anesthesiabreathing Circuit	2506V-61	FDA UDI	Class I	Active
Pediatric Ultra Flex®anesthesia Breathing Circuit	21214-440	FDA UDI	Class I	Active
Adult Ultra Flex®anesthesia Breathing Circuit	5903F-13221Z	FDA UDI	Class I	Active
Universal F2®anesthesia Breathing Circuit	D365-80Z	FDA UDI	Class I	Active
Pediatric Anesthesiabreathing Circuit	2507P-6121	FDA UDI	Class I	Active
Universal F2®	XF40	FDA UDI	Class I	Active
Universal Flex2®breathing Circuit	KNCF470-6121Z	FDA UDI	Class I	Active
Ulti-MistHME/F ICU	MS-121	FDA UDI	Class II	Active

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (100)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

Date	Recall No.	Class	Status	Reason
Feb 17, 2015	Z-1361-2015	—	terminated	Product is mislabeled as Double Swivel Connector with Suction Port and is actually Double Swivel Connector without Suction port. If the incorrect component is not identified prior to clinical use, the incorrect connector would be replaced during the case without risk to the patient and could result in a short delay of the procedure.
Sep 3, 2013	Z-2255-2013	—	terminated	Report that size 5 KLTD airways were packaged in pouches indicating a size of 2.5 and shipped to your facility. The correct size of the KLTD airway is clearly marked on the actual airway product and the physical size difference between 2.5 and 5 is distinct and obvious.
Nov 2, 2012	Z-0426-2013	—	terminated	The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO
Nov 2, 2012	Z-0420-2013	—	terminated	The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO
Nov 2, 2012	Z-0421-2013	—	terminated	The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO
Nov 2, 2012	Z-0418-2013	—	terminated	The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO
Nov 2, 2012	Z-0419-2013	—	terminated	The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO
Nov 2, 2012	Z-0425-2013	—	terminated	The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO
Nov 2, 2012	Z-0427-2013	—	terminated	The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO
Nov 2, 2012	Z-0423-2013	—	terminated	The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO
Nov 2, 2012	Z-0424-2013	—	terminated	The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO
Nov 2, 2012	Z-0422-2013	—	terminated	The firm received two complaints from a user facility in New Jersey regarding color-coded EtO sterilization indicators on the primary device packaging that did not undergo the expected color change. The complainant reported devices that had pink color indicators when the product packaging specified that the color should change from pink to yellow (or brown) if the product had subjected to an EtO
Aug 23, 2012	Z-2272-2013	—	terminated	King Systems received a customer complaint indicating that the customer had ordered a breathing circuit with a Latex breathing bag. The product they received contained a Latex breathing bag, but was labeled as non-latex.
Jan 24, 2011	Z-1889-2011	—	terminated	The firm is conducting a subrecall of facetent masks because the masks could have a sticky substance on the inside or outside of the mask that may manifest itself 6-8 months after the manufacture date of the product. The sticky substance could result in inconvenience or in some remote cases cause patient harm.
Jan 24, 2011	Z-1879-2011	—	terminated	The firms contract manufacturer reported that the products were below the specification for hardness. This could contribute to a higher incidence of problems during the insertion and final positioning of the airway in the patient. In rare instances the softness of the tube could cause the tube to fold over.
Jan 24, 2011	Z-1888-2011	—	terminated	The firm is conducting a subrecall of facetent masks because the masks could have a sticky substance on the inside or outside of the mask that may manifest itself 6-8 months after the manufacture date of the product. The sticky substance could result in inconvenience or in some remote cases cause patient harm.
Jan 24, 2011	Z-1890-2011	—	terminated	The firm is conducting a subrecall of facetent masks because the masks could have a sticky substance on the inside or outside of the mask that may manifest itself 6-8 months after the manufacture date of the product. The sticky substance could result in inconvenience or in some remote cases cause patient harm.
Jan 24, 2011	Z-1887-2011	—	terminated	The firm is conducting a subrecall of facetent masks because the masks could have a sticky substance on the inside or outside of the mask that may manifest itself 6-8 months after the manufacture date of the product. The sticky substance could result in inconvenience or in some remote cases cause patient harm.
Jan 24, 2011	Z-1892-2011	—	terminated	The firm is conducting a subrecall of facetent masks because the masks could have a sticky substance on the inside or outside of the mask that may manifest itself 6-8 months after the manufacture date of the product. The sticky substance could result in inconvenience or in some remote cases cause patient harm.
Jan 24, 2011	Z-1878-2011	—	terminated	The firms contract manufacturer reported that the products were below the specification for hardness. This could contribute to a higher incidence of problems during the insertion and final positioning of the airway in the patient. In rare instances the softness of the tube could cause the tube to fold over.
Jan 24, 2011	Z-1891-2011	—	terminated	The firm is conducting a subrecall of facetent masks because the masks could have a sticky substance on the inside or outside of the mask that may manifest itself 6-8 months after the manufacture date of the product. The sticky substance could result in inconvenience or in some remote cases cause patient harm.
Jan 14, 2011	Z-1718-2011	—	terminated	King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca
Jan 14, 2011	Z-1706-2011	—	terminated	King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca
Jan 14, 2011	Z-1714-2011	—	terminated	King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca
Jan 14, 2011	Z-1720-2011	—	terminated	King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca
Jan 14, 2011	Z-1721-2011	—	terminated	King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca
Jan 14, 2011	Z-1707-2011	—	terminated	King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca
Jan 14, 2011	Z-1710-2011	—	terminated	King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca
Jan 14, 2011	Z-1717-2011	—	terminated	King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca
Jan 14, 2011	Z-1713-2011	—	terminated	King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca
Jan 14, 2011	Z-1712-2011	—	terminated	King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca
Jan 14, 2011	Z-1705-2011	—	terminated	King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca
Jan 14, 2011	Z-1708-2011	—	terminated	King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca
Jan 14, 2011	Z-1715-2011	—	terminated	King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca
Jan 14, 2011	Z-1709-2011	—	terminated	King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca
Jan 14, 2011	Z-1719-2011	—	terminated	King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca
Jan 14, 2011	Z-1716-2011	—	terminated	King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca
Jan 14, 2011	Z-1711-2011	—	terminated	King Systems has been notified by Triad Group, our supplier of sterile lubricating jelly, that a recall has been initiated for this product because the product may be "inadequately sterilized" and use of this product may result in "patient infection". Because this particular sterile lubricating jelly is packaged in the KING LT-D Kit and KING LTS-D Kit, King Systems is sending a Notice of the Reca
Dec 15, 2009	Z-0978-2011	—	terminated	King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat
Dec 15, 2009	Z-0986-2011	—	terminated	King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat
Dec 15, 2009	Z-0975-2011	—	terminated	King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat
Dec 15, 2009	Z-0980-2011	—	terminated	King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat
Dec 15, 2009	Z-0976-2011	—	terminated	King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat
Dec 15, 2009	Z-0982-2011	—	terminated	King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat
Dec 15, 2009	Z-0984-2011	—	terminated	King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat
Dec 15, 2009	Z-0985-2011	—	terminated	King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat
Dec 15, 2009	Z-0983-2011	—	terminated	King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat
Dec 15, 2009	Z-0974-2011	—	terminated	King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat
Dec 15, 2009	Z-0977-2011	—	terminated	King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat
Dec 15, 2009	Z-0981-2011	—	terminated	King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat
Dec 15, 2009	Z-0979-2011	—	terminated	King Systems was issued a warning letter from the Center for Devices and Radiological Health, Office of Compliance on October 28, 2009. The warning letter asserts that Kings Systems KLT(S)-D airway exceeds cleared indications in that it is promoted for "airway management in patients over 4 feet in height, for controlled or spontaneous ventilation, difficult and emergent airway cases, and ambulat
Aug 1, 2008	Z-0789-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0745-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0795-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0809-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0730-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0794-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0721-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0757-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0691-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0701-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0804-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0813-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0685-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0687-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0729-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0734-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0758-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0807-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0696-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0699-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0783-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0816-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0709-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0700-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0714-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0689-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0805-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0812-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0742-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0748-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0796-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0782-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0790-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0736-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0800-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0724-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0683-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0761-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0814-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0682-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0679-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0764-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0681-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0773-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0722-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0740-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0752-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0772-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.
Aug 1, 2008	Z-0785-2009	—	terminated	The inner line may be severed or broken into two pieces, thus hindering the delivery of oxygen and anesthetics to the patient and possibly elevated patient carbon dioxide levels.